<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_full.rss">
    <title>Pharmaceutical Technology Magazine</title>

    <link>http://pharmtech.findpharma.com/pharmtech</link>

    <description>A publication providing practical information on pharmaceutical manufacturing. Content focuses on
    applied R&amp;amp;D technology, process control and computer-integrated manufacturing, biotechnology and technical
    management.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Lilly-to-Establish-Registry-of-its-Payments-to-Phy/ArticleStandard/Article/detail/555701?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-to-Cut-up-to-850-Jobs/ArticleStandard/Article/detail/555724?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Pediatric-Drug-Rulemaking-Open-for-Public-Comment/ArticleStandard/Article/detail/555700?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/WirelessHART-Gains-IEC-Approval/ArticleStandard/Article/detail/555698?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Contract-Manufacturers-and-Pharmaceutical-Ingredie/ArticleStandard/Article/detail/553579?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Ionic-Liquids-in-the-Chemical-Synthesis-of-Pharmae/ArticleStandard/Article/detail/552614?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/PharmTech-media-kit---emailable-version/ArticleStandard/Article/detail/555831?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/2008-June-PBA-Statement/ArticleStandard/Article/detail/554311?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/2009-PharmTech-Media-Kit/ArticleStandard/Article/detail/554303?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/2009-Editorial-Calendar/ArticleStandard/Article/detail/554316?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/2009-e-media-kit/ArticleStandard/Article/detail/555155?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/House-Questions-FDAs-Priorities/ArticleStandard/Article/detail/552660?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Committee-on-Energy-and-C/ArticleStandard/Article/detail/552707?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Outlines-Rules-on-Genetically-Engineered-Anima/ArticleStandard/Article/detail/552661?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Wyeth-Prepares-for-Supreme-Court-Preemption-Case/ArticleStandard/Article/detail/552662?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Study-Promotes-HatchndashWaxman-Model-for-Biologic/ArticleStandard/Article/detail/552658?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nano-Ships-Designed-for-Drug-Delivery/ArticleStandard/Article/detail/550871?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/ImClone-Systems-Rejects-Bid-by-Bristol-Myers-Squib/ArticleStandard/Article/detail/550870?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Commences-Tender-Off/ArticleStandard/Article/detail/550918?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/MannKind-Will-Help-Patients-Switch-from-Exubera-to/ArticleStandard/Article/detail/550869?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-Warning-Letters-and-Import-Alert-on-Ran/ArticleStandard/Article/detail/550866?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Preparation-for-ICH-Brussels-Begins/ArticleStandard/Article/detail/550872?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Quarterly-Reports-Notify-Public-of-Potential-Safet/ArticleStandard/Article/detail/550867?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Qualification-Pitfalls-and-How-to-Avoid-Them/ArticleStandard/Article/detail/550458?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/September-2008-Editors-Picks-Products-from-LiquaJe/ArticleStandard/Article/detail/550121?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Dispensing-Biopharmaceuticals-with-Piston-and-Peri/ArticleStandard/Article/detail/550135?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-US-FDA-Orphan-Drug-Product-Program/ArticleStandard/Article/detail/550661?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Takes-First-Step-in-Modernizing-CGMPs/ArticleStandard/Article/detail/548934?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/CEFIC-Forms-REACH-Service/ArticleStandard/Article/detail/548937?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/New-FDA-Website-Provides-Information-about-DTC-Ads/ArticleStandard/Article/detail/548938?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-FTC-Asks-Teva-and-Barr-Fo/ArticleStandard/Article/detail/549003?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Updates-Bioequivalence-Guidelines/ArticleStandard/Article/detail/548936?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Color-vs-Appearance-Choose-the-appropriate-instrum/ArticleStandard/Article/detail/548039?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing/Global-Biochemical-Profiling-for-Bioprocessing-Opt/ArticleStandard/Article/detail/548038?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Solid-Dose-Calibrator-for-Karl-Fischer-Titration/ArticleStandard/Article/detail/547783?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Managing-the-Regulatory-Submission-Project/ArticleStandard/Article/detail/547784?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Valeant-Collabora/ArticleStandard/Article/detail/547486?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/NAS-Launches-and-NME-Approvals-Declined-in-2007/ArticleStandard/Article/detail/547457?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Testing/USP-Revises-Potency-Spec-for-Levothyroxine-Sodium-/ArticleStandard/Article/detail/547455?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Boehringer-Ingelheim-Partners-with-Chinese-Interme/ArticleStandard/Article/detail/547456?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Setting-a-Regulatory-Framework-for-Nanotechnology/ArticleStandard/Article/detail/544940?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Clinical-Outsourcing-Steams-Ahead/ArticleStandard/Article/detail/544941?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Advances-in-Green-Chemistry-for-Pharmaceutical-App/ArticleStandard/Article/detail/544937?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Continuous-Processing-Moving-with-or-against-the-M/ArticleStandard/Article/detail/549164?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Testing+Article/Running-a-Marathon-in-Flip-Flops-ndash-Part-2-The-/ArticleStandard/Article/detail/550367?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Capsules/ArticleStandard/Article/detail/549171?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Drug-Imports-under-Scrutiny/ArticleStandard/Article/detail/549162?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/The-Potential-of-Continuous-Sterile-Manufacturing/ArticleStandard/Article/detail/550369?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Hits-and-Strikes/ArticleStandard/Article/detail/549160?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/A-Catalyst-for-Environmental-Consciousness/ArticleStandard/Article/detail/550366?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Big-Deals/ArticleStandard/Article/detail/549167?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Sustainability-Surprises/ArticleStandard/Article/detail/549163?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Dirty-Hands/ArticleStandard/Article/detail/549158?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Criticality-Management-of-a-Drug-Product-and-its-M/ArticleStandard/Article/detail/549165?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Make-Yourself-Count/ArticleStandard/Article/detail/549159?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Chiral-Separations/ArticleStandard/Article/detail/550368?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Dielectric-Spectroscopy-Choosing-the-Right-Approac/ArticleStandard/Article/detail/549166?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Achieving-Enantioselectivity/ArticleStandard/Article/detail/549170?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Global-Warming-Heats-Up-Need-for-Malaria-Vaccine/ArticleStandard/Article/detail/549168?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/549161?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Report-From-India/ArticleStandard/Article/detail/549536?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Industrial-Applications-of-Whole-Cell-Biocatalysis/ArticleStandard/Article/detail/548828?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Highly-Efficient-Olefin-Metathesis-Catalysts/ArticleStandard/Article/detail/548825?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Manufacturing-Considerations-for-Sourcing-GMP-Ferm/ArticleStandard/Article/detail/548826?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Power-Ultrasound-and-the-Production-of-Mesoscopic-/ArticleStandard/Article/detail/548822?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/High-Potency-APIs-Containment-and-Handling-Issues/ArticleStandard/Article/detail/548824?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Epedigree-in-the-Pharmaceutical-Supply-Chain/ArticleStandard/Article/detail/548823?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Expansion-Activity-of-CMOs/ArticleStandard/Article/detail/548827?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Economic-Impact-Increases-but-Employment-Falls-for/ArticleStandard/Article/detail/545161?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/King-Pharmaceuticals-Bids-14-Billion-for-Alpharma/ArticleStandard/Article/detail/545160?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Time-is-Running-out-for-Innovation-Awards/ArticleStandard/Article/detail/545141?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Public-Comment-on-Cough-and-Cold-Meds-for-Kids/ArticleStandard/Article/detail/545159?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Finalizes-Labeling-Changes-Rule/ArticleStandard/Article/detail/545146?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-Gilead-Sciences-to-Expand/ArticleStandard/Article/detail/545230?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-to-Acquire-Talecris-B/ArticleStandard/Article/detail/543542?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Misuse-of-Narcotics-May-Call-for-Additional-Doctor/ArticleStandard/Article/detail/543483?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Expresses-Trade-Concerns-with-REACH-Implemen/ArticleStandard/Article/detail/543486?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Testing/USP-Opens-Site-in-Brazil/ArticleStandard/Article/detail/543484?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/August-2008-Editors-Picks-Products-from-OYSTAR-Man/ArticleStandard/Article/detail/542946?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/After-Formaldehyde-Comparing-Alternative-Decontami/ArticleStandard/Article/detail/542595?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/How-to-Be-Green-in-a-CGMP-Regulated-Environment/ArticleStandard/Article/detail/542939?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Seeks-Contractors-for-Sentinel-System/ArticleStandard/Article/detail/542060?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Actavis-Voluntary-Recalls-Products-for-GMP-Violati/ArticleStandard/Article/detail/542065?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Rejects-Roches-/ArticleStandard/Article/detail/542276?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/FDA-Releases-Draft-Guidance-on-Residual-Solvents/ArticleStandard/Article/detail/542062?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sterile-Manufacturing-Draft-Guidance-Provides-Appl/ArticleStandard/Article/detail/542067?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Magnetic-Mixers-How-Are-They-Different/ArticleStandard/Article/detail/535012?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/BMS-Bids-45-Billion-for-ImClone-Systems/ArticleStandard/Article/detail/534324?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Meda-will-Acquire-Valeant/ArticleStandard/Article/detail/534390?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Revised-Discussion-Draft-of-FDA-Globalization-Act-/ArticleStandard/Article/detail/534325?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Fire-rated-pallets-What-you-need-to-know/ArticleStandard/Article/detail/534538?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDAs-Complete-Responses-Commence/ArticleStandard/Article/detail/534316?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/User-Fee-Rates-for-FY-2009-Announced/ArticleStandard/Article/detail/534323?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Fundamentals-Are-Strong-for-Global-CRO-Market/ArticleStandard/Article/detail/533225?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing-Practices-Scrutinized-by-Congress/ArticleStandard/Article/detail/533228?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/533290?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Saved-by-the-Delay/ArticleStandard/Article/detail/534710?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/FDA-and-Medicare-at-Odds/ArticleStandard/Article/detail/534698?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Suspicious-Times/ArticleStandard/Article/detail/534700?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Charting-Advances-at-CRS/ArticleStandard/Article/detail/534699?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2008-10-06T21:39:43Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Lilly-to-Establish-Registry-of-its-Payments-to-Phy/ArticleStandard/Article/detail/555701?ref=25">

    <title>Lilly to Establish Registry of its Payments to Physicians</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Lilly-to-Establish-Registry-of-its-Payments-to-Phy/ArticleStandard/Article/detail/555701?ref=25</link>

    <description>Eli Lilly and Company plans to launch an online registry of its payments to physicians in
    2009.</description>

    <dc:date>2008-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555701null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-to-Cut-up-to-850-Jobs/ArticleStandard/Article/detail/555724?ref=25">

    <title>Company and People Notes: GSK to Cut up to 850 Jobs; Zerhouni to Leave NIH; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-to-Cut-up-to-850-Jobs/ArticleStandard/Article/detail/555724?ref=25</link>

    <description>Also, Alpharma advises shareholders to reject King's offer; ImClone rejects raised BMS offer;
    Immunogen appoints Daniel M. Junius, more...</description>

    <dc:date>2008-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555724null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Pediatric-Drug-Rulemaking-Open-for-Public-Comment/ArticleStandard/Article/detail/555700?ref=25">

    <title>Pediatric Drug Rulemaking Open for Public Comment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Pediatric-Drug-Rulemaking-Open-for-Public-Comment/ArticleStandard/Article/detail/555700?ref=25</link>

    <description>A public meeting is being held today to discuss over-the-counter cough and cold medications for
    pediatric use.</description>

    <dc:date>2008-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555700null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/WirelessHART-Gains-IEC-Approval/ArticleStandard/Article/detail/555698?ref=25">

    <title>WirelessHART Gains IEC Approval</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/WirelessHART-Gains-IEC-Approval/ArticleStandard/Article/detail/555698?ref=25</link>

    <description>The International Electrotechnical Commission (IEC) has approved HART 7.1, the WirelessHART
    Communication Specification, as a Publicly Available Specification (IEC/PAS 62591Ed.1). WirelessHART is the first
    industrial wireless communication technology to achieve this level of approval.</description>

    <dc:date>2008-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555698null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Contract-Manufacturers-and-Pharmaceutical-Ingredie/ArticleStandard/Article/detail/553579?ref=25">

    <title>Contract Manufacturers and Pharmaceutical Ingredient Suppliers Gather for CPhI</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Contract-Manufacturers-and-Pharmaceutical-Ingredie/ArticleStandard/Article/detail/553579?ref=25</link>

    <description>SAFC, Regis Technologies, Carbogen Amcis, Cambridge Major Laboratories, and AMRI are among the
    companies at CPhI Worldwide in Frankfurt this week that are moving forward with expansions.</description>

    <dc:date>2008-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/553579null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Ionic-Liquids-in-the-Chemical-Synthesis-of-Pharmae/ArticleStandard/Article/detail/552614?ref=25">

    <title>Ionic Liquids in the Chemical Synthesis of Pharmaeuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Ionic-Liquids-in-the-Chemical-Synthesis-of-Pharmae/ArticleStandard/Article/detail/552614?ref=25</link>

    <description>Ionic liquids provide an alternative to certain solvents in select reactions used to synthesize
    intermediates and active pharmaceutical ingredients.</description>

    <dc:date>2008-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552614null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/PharmTech-media-kit---emailable-version/ArticleStandard/Article/detail/555831?ref=25">

    <title>PharmTech media kit - emailable version</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/PharmTech-media-kit---emailable-version/ArticleStandard/Article/detail/555831?ref=25</link>

    <description>PharmTech media kit email version</description>

    <dc:date>2008-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555831null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/2008-June-PBA-Statement/ArticleStandard/Article/detail/554311?ref=25">

    <title>2008 June PBA Statement</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/2008-June-PBA-Statement/ArticleStandard/Article/detail/554311?ref=25</link>

    <description>2008 June BPA Statement</description>

    <dc:date>2008-09-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/554311null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/2009-PharmTech-Media-Kit/ArticleStandard/Article/detail/554303?ref=25">

    <title>2009 PharmTech Media Kit</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/2009-PharmTech-Media-Kit/ArticleStandard/Article/detail/554303?ref=25</link>

    <description>2009 PharmTech Media Kit</description>

    <dc:date>2008-09-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/554303null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/2009-Editorial-Calendar/ArticleStandard/Article/detail/554316?ref=25">

    <title>2009 Editorial Calendar</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/2009-Editorial-Calendar/ArticleStandard/Article/detail/554316?ref=25</link>

    <description>2009 Editorial Calendar</description>

    <dc:date>2008-09-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/554316null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/2009-e-media-kit/ArticleStandard/Article/detail/555155?ref=25">
    <title>2009 e-media kit</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/2009-e-media-kit/ArticleStandard/Article/detail/555155?ref=25</link>

    <description>2009 e-Media kit</description>

    <dc:date>2008-09-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402008/555155null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/House-Questions-FDAs-Priorities/ArticleStandard/Article/detail/552660?ref=25">

    <title>House Questions FDA's Priorities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/House-Questions-FDAs-Priorities/ArticleStandard/Article/detail/552660?ref=25</link>

    <description>In a Sept. 17 letter to FDA Commissioner Andrew C. von Eschenbach, Rep. Henry Waxman (D-CA) questions
    the agency's priorities, specifically poking at FDA's political appointees and whether they are promoting industry
    at the expense of the public's health.</description>

    <dc:date>2008-09-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552660null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Committee-on-Energy-and-C/ArticleStandard/Article/detail/552707?ref=25">

    <title>Company and People Notes: Committee on Energy and Commerce Expands Ranbaxy Probe; Eli Lilly Appoints John C.
    Lechleiter Chairman of the Board; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Committee-on-Energy-and-C/ArticleStandard/Article/detail/552707?ref=25</link>

    <description>Also, Zentiva accepts Sanofi's increased takeover bid, Oriel Therapeutics appoints Richard Fuller CEO,
    more...</description>

    <dc:date>2008-09-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552707null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Outlines-Rules-on-Genetically-Engineered-Anima/ArticleStandard/Article/detail/552661?ref=25">

    <title>FDA Outlines Rules on Genetically Engineered Animals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Outlines-Rules-on-Genetically-Engineered-Anima/ArticleStandard/Article/detail/552661?ref=25</link>

    <description>In an effort to clarify its policy on the use and creation of genetically engineered animals (GE
    animals), the US Food and Drug Administration released the draft guidance &amp;#34;The Regulation of Genetically
    Engineered Animals Containing Heritable rDNA Constructs&amp;#34; on September 18.</description>

    <dc:date>2008-09-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552661null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Wyeth-Prepares-for-Supreme-Court-Preemption-Case/ArticleStandard/Article/detail/552662?ref=25">

    <title>Wyeth Prepares for Supreme Court Preemption Case</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Wyeth-Prepares-for-Supreme-Court-Preemption-Case/ArticleStandard/Article/detail/552662?ref=25</link>

    <description>On November 3, the US Supreme Court will hear the case of Wyeth v. Levine, in which the drug company
    has challenged the ruling of a Vermont Supreme Court decision to award Diana Levine $6.8 million.</description>

    <dc:date>2008-09-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552662null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Study-Promotes-HatchndashWaxman-Model-for-Biologic/ArticleStandard/Article/detail/552658?ref=25">

    <title>Study Promotes Hatch&amp;amp;ndash;Waxman Model for Biologics Exclusivity</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Study-Promotes-HatchndashWaxman-Model-for-Biologic/ArticleStandard/Article/detail/552658?ref=25</link>

    <description>A new study concludes that an approval pathway for affordable follow-on biologics should be based on
    the Hatch&amp;amp;ndash;Waxman Act of 1984.</description>

    <dc:date>2008-09-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392008/552658null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nano-Ships-Designed-for-Drug-Delivery/ArticleStandard/Article/detail/550871?ref=25">

    <title>Nano &amp;#34;Ships&amp;#34; Designed for Drug Delivery</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Nano-Ships-Designed-for-Drug-Delivery/ArticleStandard/Article/detail/550871?ref=25</link>

    <description>Researchers from the University of California San Diego, UC&amp;amp;Acirc;&amp;amp;nbsp; Santa
    Barbara, and MIT have developed nanometer-sized hybrid structures carrying anti-cancer drugs and quantum dot
    imaging agents.</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550871null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/ImClone-Systems-Rejects-Bid-by-Bristol-Myers-Squib/ArticleStandard/Article/detail/550870?ref=25">

    <title>ImClone Systems Rejects Bid by Bristol-Myers Squibb</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/ImClone-Systems-Rejects-Bid-by-Bristol-Myers-Squib/ArticleStandard/Article/detail/550870?ref=25</link>

    <description>The biopharmaceutical company ImClone Systems rejected Bristol-Myers Squibb's previously announced bid
    of $60 per share in cash or $4.5 billion for acquiring ImClone, citing the bid as
    &amp;#34;inadequate.&amp;#34;</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550870null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Commences-Tender-Off/ArticleStandard/Article/detail/550918?ref=25">

    <title>Company and People Notes: King Commences Tender Offer for Alpharma; Genentech Appoints Morgan Sheng VP of
    Neuroscience; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Commences-Tender-Off/ArticleStandard/Article/detail/550918?ref=25</link>

    <description>Also, Quintiles to expand Singapore operations; Christine A. Poon, chairman of Johnson &amp;amp;amp;
    Johnson's pharmaceuticals group, to retire; more...</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550918null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/MannKind-Will-Help-Patients-Switch-from-Exubera-to/ArticleStandard/Article/detail/550869?ref=25">

    <title>MannKind Will Help Patients Switch from &amp;#34;Exubera&amp;#34; to &amp;#34;Technosphere
    Insulin&amp;#34;</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/MannKind-Will-Help-Patients-Switch-from-Exubera-to/ArticleStandard/Article/detail/550869?ref=25</link>

    <description>MannKind and Pfizer (New York) agreed that the former company will help patients who need inhaled
    insulin switch from Pfizer's &amp;#34;Exubera&amp;#34; medicine to MannKind's &amp;#34;Technosphere
    Insulin&amp;#34; drug.</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550869null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-Warning-Letters-and-Import-Alert-on-Ran/ArticleStandard/Article/detail/550866?ref=25">

    <title>FDA Issues Warning Letters and Import Alert on Ranbaxy Laboratories</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-Warning-Letters-and-Import-Alert-on-Ran/ArticleStandard/Article/detail/550866?ref=25</link>

    <description>The US Food and Drug Administration has issued two warning letters to Ranbaxy
    Laboratories.</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Preparation-for-ICH-Brussels-Begins/ArticleStandard/Article/detail/550872?ref=25">

    <title>Preparation for ICH-Brussels Begins</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Preparation-for-ICH-Brussels-Begins/ArticleStandard/Article/detail/550872?ref=25</link>

    <description>In November, representatives to the International Conference on Harmonization will meet in Brussels,
    Belgium, to discuss several international cooperation initiatives, including ICH Q10: Pharmaceutical Quality System
    and ICH Q8R: Pharmaceutical Development.</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550872null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Quarterly-Reports-Notify-Public-of-Potential-Safet/ArticleStandard/Article/detail/550867?ref=25">

    <title>Quarterly Reports Notify Public of Potential Safety Issues</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Quarterly-Reports-Notify-Public-of-Potential-Safet/ArticleStandard/Article/detail/550867?ref=25</link>

    <description>Earlier this month, the US Food and Drug Administration announced that it will be posting quarterly
    reports on its website regarding potential drug safety issues.</description>

    <dc:date>2008-09-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550867null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Qualification-Pitfalls-and-How-to-Avoid-Them/ArticleStandard/Article/detail/550458?ref=25">

    <title>Qualification Pitfalls and How to Avoid Them</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Qualification-Pitfalls-and-How-to-Avoid-Them/ArticleStandard/Article/detail/550458?ref=25</link>

    <description>Qualification demonstrates that equipment is what it is purported to be and does what it is supposed
    to do. Installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) are the
    three steps of equipment qualification.</description>

    <dc:date>2008-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550458null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/September-2008-Editors-Picks-Products-from-LiquaJe/ArticleStandard/Article/detail/550121?ref=25">

    <title>September 2008 Editor's Picks: Products from LiquaJet and Yokogawa</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/September-2008-Editors-Picks-Products-from-LiquaJe/ArticleStandard/Article/detail/550121?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the September 2008 edition from LiquaJet and Yokogawa.</description>

    <dc:date>2008-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550121null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Dispensing-Biopharmaceuticals-with-Piston-and-Peri/ArticleStandard/Article/detail/550135?ref=25">

    <title>Dispensing Biopharmaceuticals with Piston and Peristaltic Pumps</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Dispensing-Biopharmaceuticals-with-Piston-and-Peri/ArticleStandard/Article/detail/550135?ref=25</link>

    <description>Piston pumps have been a traditional liquid-filling technology for biopharmaceutical manufacturers,
    but new challenges, stricter validation requirements, and design innovations have led manufacturers to consider
    peristaltic filling technology.</description>

    <dc:date>2008-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550135null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-US-FDA-Orphan-Drug-Product-Program/ArticleStandard/Article/detail/550661?ref=25">

    <title>The U.S. FDA Orphan Drug Product Program</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-US-FDA-Orphan-Drug-Product-Program/ArticleStandard/Article/detail/550661?ref=25</link>

    <description>The Orphan Drug White Paper provides a description of the history and content of the Orphan Drug Act
    including various statistics through 2005. The paper also describes the orphan drug designation and orphan drug
    grant processes in sufficient detail for applicants to be able to file an orphan drug designation or grant
    request.</description>

    <dc:date>2008-09-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550661null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Takes-First-Step-in-Modernizing-CGMPs/ArticleStandard/Article/detail/548934?ref=25">

    <title>FDA Takes &amp;#34;First Step&amp;#34; in Modernizing CGMPs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Takes-First-Step-in-Modernizing-CGMPs/ArticleStandard/Article/detail/548934?ref=25</link>

    <description>FDA has issued a Final Rule titled &amp;#34;Amendments to the Current Good Manufacturing Practice
    Regulations for Finished Pharmaceuticals.&amp;#34;</description>

    <dc:date>2008-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548934null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/CEFIC-Forms-REACH-Service/ArticleStandard/Article/detail/548937?ref=25">

    <title>CEFIC Forms REACH Service</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/CEFIC-Forms-REACH-Service/ArticleStandard/Article/detail/548937?ref=25</link>

    <description>The European Chemical Industry Council and five national chemical associations representing France,
    Germany, Italy, Spain, and the United Kingdom, have launched ReachLink. ReachLink is a company founded to help
    companies participate in the Substance Information Exchange Forum (SIEF), which is designed as an
    information-sharing vehicle to facilitate companies in meeting requirements under REACH</description>

    <dc:date>2008-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548937null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/New-FDA-Website-Provides-Information-about-DTC-Ads/ArticleStandard/Article/detail/548938?ref=25">

    <title>New FDA Website Provides Information about DTC Ads</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/New-FDA-Website-Provides-Information-about-DTC-Ads/ArticleStandard/Article/detail/548938?ref=25</link>

    <description>The US Food and Drug Administration launched a new website to educate the general public about
    direct-to-consumer (DTC) advertising of prescription medications.</description>

    <dc:date>2008-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548938null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-FTC-Asks-Teva-and-Barr-Fo/ArticleStandard/Article/detail/549003?ref=25">

    <title>Company and People Notes: FTC Asks Teva and Barr For Additional Information, GSK's Chris Viehbacher to Leave
    Company, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-FTC-Asks-Teva-and-Barr-Fo/ArticleStandard/Article/detail/549003?ref=25</link>

    <description>Also, Human Genome Sciences enters pact with Hospira, Zosano Pharma names Gail Schulze chair and CEO,
    more...</description>

    <dc:date>2008-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549003null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Updates-Bioequivalence-Guidelines/ArticleStandard/Article/detail/548936?ref=25">

    <title>FDA Updates Bioequivalence Guidelines</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Updates-Bioequivalence-Guidelines/ArticleStandard/Article/detail/548936?ref=25</link>

    <description>The US Food and Drug Administration has updated its draft bioequivalence recommendations for several
    products, and added 66 new draft product-specific guidelines since October 2007.</description>

    <dc:date>2008-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548936null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Color-vs-Appearance-Choose-the-appropriate-instrum/ArticleStandard/Article/detail/548039?ref=25">

    <title>Color vs. Appearance: Choose the appropriate instrument geometry for your color measuring instrument</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Color-vs-Appearance-Choose-the-appropriate-instrum/ArticleStandard/Article/detail/548039?ref=25</link>

    <description>With the number of color measuring instruments on the market, how do you choose the most appropriate
    one? It helps to understand the difference between measuring color and measuring appearance.</description>

    <dc:date>2008-09-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/548039null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing/Global-Biochemical-Profiling-for-Bioprocessing-Opt/ArticleStandard/Article/detail/548038?ref=25">

    <title>Global Biochemical Profiling for Bioprocessing Optimization</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing/Global-Biochemical-Profiling-for-Bioprocessing-Opt/ArticleStandard/Article/detail/548038?ref=25</link>

    <description>It is widely understood that the production phase of bioprocessing can have a significant impact on
    the overall profitability of the biopharmaceutical. Organizations must analyze everything from total protein
    production level to glycosylation patterns as well as overall quality and stability. Given the large numbers of
    variables involved&amp;amp;acirc;&amp;amp;euro;&amp;amp;rdquo;especially in the composition of media
    nutrients&amp;amp;acirc;&amp;amp;euro;&amp;amp;rdquo;it is has been difficult to achieve globally optimal
    conditions using traditional analysis methods. This paper provides an overview of the type of relevant information
    that global biochemical profiling (metabolomics) can provide. Through this global analysis, one can not only
    measure these changes but also put them into biological context and&amp;amp;mdash;most
    importantly&amp;amp;mdash;into application.</description>

    <dc:date>2008-09-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/548038null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Solid-Dose-Calibrator-for-Karl-Fischer-Titration/ArticleStandard/Article/detail/547783?ref=25">

    <title>Solid Dose Calibrator for Karl Fischer Titration</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Solid-Dose-Calibrator-for-Karl-Fischer-Titration/ArticleStandard/Article/detail/547783?ref=25</link>

    <description>This article discusses the advantages of using a tablet as a standard for Karl Fischer titrations, and
    compares the results obtained using a tablet standard with those from two other commercial standards based on other
    delivery systems.</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547783null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Managing-the-Regulatory-Submission-Project/ArticleStandard/Article/detail/547784?ref=25">

    <title>Managing the Regulatory Submission Project</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Managing-the-Regulatory-Submission-Project/ArticleStandard/Article/detail/547784?ref=25</link>

    <description>Preparing a regulatory submission document can be costly in regards to resources and time. It is
    important to follow project management principles to ensure a cost effective and successful submission. This paper
    provides a summary of the overall process for managing a regulatory submission project.</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547784null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Valeant-Collabora/ArticleStandard/Article/detail/547486?ref=25">

    <title>Company and People Notes: GSK and Valeant Collaborate on Investigational Drug, Aptuit Appoints Timothy C.
    Tyson Executive Chairman and Acting CEO, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Valeant-Collabora/ArticleStandard/Article/detail/547486?ref=25</link>

    <description>Also, Novartis stops development on &amp;#34;Aurograb,&amp;#34; Zealand Pharma appoints David H.
    Solomon as CEO, more...</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547486null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/NAS-Launches-and-NME-Approvals-Declined-in-2007/ArticleStandard/Article/detail/547457?ref=25">

    <title>NAS Launches and NME Approvals Declined in 2007</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/NAS-Launches-and-NME-Approvals-Declined-in-2007/ArticleStandard/Article/detail/547457?ref=25</link>

    <description>Companies launched 25 new active substances in 2007, a decline of 19% from the previous year,
    according to a new report from Parexel International.</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547457null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Testing/USP-Revises-Potency-Spec-for-Levothyroxine-Sodium-/ArticleStandard/Article/detail/547455?ref=25">

    <title>USP Revises Potency Spec for Levothyroxine Sodium Tablets</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Testing/USP-Revises-Potency-Spec-for-Levothyroxine-Sodium-/ArticleStandard/Article/detail/547455?ref=25</link>

    <description>USP announced an interim revision to its monograph for levothyroxine sodium tablets, which will become
    official in USP 32-NF 27.</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Boehringer-Ingelheim-Partners-with-Chinese-Interme/ArticleStandard/Article/detail/547456?ref=25">

    <title>Boehringer Ingelheim Partners with Chinese Intermediates Producer</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Boehringer-Ingelheim-Partners-with-Chinese-Interme/ArticleStandard/Article/detail/547456?ref=25</link>

    <description>Boehringer Ingelheim and and Hisoar (Taizhou, China), a pharmaceutical production company, formed a
    strategic production alliance in China.</description>

    <dc:date>2008-09-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362008/547456null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Setting-a-Regulatory-Framework-for-Nanotechnology/ArticleStandard/Article/detail/544940?ref=25">

    <title>Setting a Regulatory Framework for Nanotechnology</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Setting-a-Regulatory-Framework-for-Nanotechnology/ArticleStandard/Article/detail/544940?ref=25</link>

    <description>The US Food and Drug Administration will hold a public meeting this month to gain public input on
    implementing the recommendations of the Nanotechnology Task Force report, taking another step closer to setting a
    regulatory framework for nanotechnology for pharmaceuticals and medical devices.</description>

    <dc:date>2008-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/544940null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Clinical-Outsourcing-Steams-Ahead/ArticleStandard/Article/detail/544941?ref=25">

    <title>Clinical Outsourcing Steams Ahead</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Clinical-Outsourcing-Steams-Ahead/ArticleStandard/Article/detail/544941?ref=25</link>

    <description>CMC service providers are doing well, but clinical and preclinical CROs are doing even
    better.</description>

    <dc:date>2008-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/544941null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Advances-in-Green-Chemistry-for-Pharmaceutical-App/ArticleStandard/Article/detail/544937?ref=25">

    <title>Advances in Green Chemistry for Pharmaceutical Applications</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Advances-in-Green-Chemistry-for-Pharmaceutical-App/ArticleStandard/Article/detail/544937?ref=25</link>

    <description>The pharmaceutical majors deploy green-chemistry strategies to improve the synthesis of active
    pharmaceutical ingredients and intermediates.</description>

    <dc:date>2008-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/544937null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Continuous-Processing-Moving-with-or-against-the-M/ArticleStandard/Article/detail/549164?ref=25">

    <title>Continuous Processing: Moving with or against the Manufacturing Flow</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Continuous-Processing-Moving-with-or-against-the-M/ArticleStandard/Article/detail/549164?ref=25</link>

    <description>Fueled by a need to reduce costs and improve efficiencies, continuous processing may be the next
    paradigm shift in pharmaceutical manufacturing.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549164/sept_52_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Testing+Article/Running-a-Marathon-in-Flip-Flops-ndash-Part-2-The-/ArticleStandard/Article/detail/550367?ref=25">

    <title>Running a Marathon in Flip-Flops &amp;amp;ndash; Part 2: The Value of Incorporating Prerequisites into
    Equipment Qualification</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Testing+Article/Running-a-Marathon-in-Flip-Flops-ndash-Part-2-The-/ArticleStandard/Article/detail/550367?ref=25</link>

    <description>Equipment qualification is a critical step in ensuring that a product or service is provided
    accurately and consistently with regards to manufacturing and testing. The time-saving attribute of adding
    prerequisites to a qualification program, along with the benefit of gaining the ability to track and trend problem
    areas, make the addition both worthwhile and cost-effective.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550367/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550367null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Capsules/ArticleStandard/Article/detail/549171?ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Capsules/ArticleStandard/Article/detail/549171?ref=25</link>

    <description>Brief pharmaceutical news items for September 2008.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549171null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Drug-Imports-under-Scrutiny/ArticleStandard/Article/detail/549162?ref=25">

    <title>Drug Imports under Scrutiny</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Drug-Imports-under-Scrutiny/ArticleStandard/Article/detail/549162?ref=25</link>

    <description>FDA is taking several measures to ensure that imported drugs meet manufacturing
    standards.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549162null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/The-Potential-of-Continuous-Sterile-Manufacturing/ArticleStandard/Article/detail/550369?ref=25">

    <title>The Potential of Continuous Sterile Manufacturing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/The-Potential-of-Continuous-Sterile-Manufacturing/ArticleStandard/Article/detail/550369?ref=25</link>

    <description>Sterile manufacturing may be the next aspect of pharmaceutical manufacturing to consider in the
    continuous process paradigm.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550369/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550369null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Hits-and-Strikes/ArticleStandard/Article/detail/549160?ref=25">

    <title>Hits and Strikes</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Hits-and-Strikes/ArticleStandard/Article/detail/549160?ref=25</link>

    <description>Operators are hit hard by breakage problems and strike out on FDA inspections.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549160null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/A-Catalyst-for-Environmental-Consciousness/ArticleStandard/Article/detail/550366?ref=25">

    <title>A Catalyst for Environmental Consciousness</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/A-Catalyst-for-Environmental-Consciousness/ArticleStandard/Article/detail/550366?ref=25</link>

    <description>A recent book shows the links between synthesis, catalysis, and environmental
    protection.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550366/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550366null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Big-Deals/ArticleStandard/Article/detail/549167?ref=25">

    <title>Big Deals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Big-Deals/ArticleStandard/Article/detail/549167?ref=25</link>

    <description>Summer deals struck by Novartis and Lilly point to an evolution in contract services.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549167null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Sustainability-Surprises/ArticleStandard/Article/detail/549163?ref=25">

    <title>Sustainability Surprises</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Sustainability-Surprises/ArticleStandard/Article/detail/549163?ref=25</link>

    <description>Identifying the most sustainable packaging for a product is rarely a simple exercise.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549163null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Dirty-Hands/ArticleStandard/Article/detail/549158?ref=25">
    <title>Dirty Hands</title>

    <link>http://pharmtech.findpharma.com/pharmtech/IT/Dirty-Hands/ArticleStandard/Article/detail/549158?ref=25</link>

    <description>Are hypersanitation trends a result of scaremongering or a lack of faith in medicine?</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549158null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Criticality-Management-of-a-Drug-Product-and-its-M/ArticleStandard/Article/detail/549165?ref=25">

    <title>Criticality Management of a Drug Product and its Manufacturing Process</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Criticality-Management-of-a-Drug-Product-and-its-M/ArticleStandard/Article/detail/549165?ref=25</link>

    <description>Criticality management combines pharmaceutical product, process, and material knowledge and risk
    management in one approach, which is reflected in a single document.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549165null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Make-Yourself-Count/ArticleStandard/Article/detail/549159?ref=25">

    <title>Make Yourself Count</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Make-Yourself-Count/ArticleStandard/Article/detail/549159?ref=25</link>

    <description>This year, the employment survey will acknowledge the industry's best employers.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549159null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Chiral-Separations/ArticleStandard/Article/detail/550368?ref=25">

    <title>Chiral Separations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Chiral-Separations/ArticleStandard/Article/detail/550368?ref=25</link>

    <description>The selection of the chiral stationary phase is an important consideration in separating enantiomers
    when using high-performance liquid chromatography, supercritical fluid chromatography, and simulated moving bed
    chromatography.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550368/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382008/550368null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Dielectric-Spectroscopy-Choosing-the-Right-Approac/ArticleStandard/Article/detail/549166?ref=25">

    <title>Dielectric Spectroscopy: Choosing the Right Approach</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Dielectric-Spectroscopy-Choosing-the-Right-Approac/ArticleStandard/Article/detail/549166?ref=25</link>

    <description>This tutorial paper is meant to aid in dielectric-sensor selection</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549166/sept_82_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549166/sept_82_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Achieving-Enantioselectivity/ArticleStandard/Article/detail/549170?ref=25">

    <title>Achieving Enantioselectivity</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Achieving-Enantioselectivity/ArticleStandard/Article/detail/549170?ref=25</link>

    <description>Carbon&amp;amp;ndash;hydrogen functionalization, ketone &amp;amp;alpha;-alkylation, and biocatalysis
    are some recent advances in asymmetric synthesis.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549170/sept_60_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Global-Warming-Heats-Up-Need-for-Malaria-Vaccine/ArticleStandard/Article/detail/549168?ref=25">

    <title>Global Warming Heats Up Need for Malaria Vaccine</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Global-Warming-Heats-Up-Need-for-Malaria-Vaccine/ArticleStandard/Article/detail/549168?ref=25</link>

    <description>With economics and politics in the way, can we defeat the malaria epidemic before it defeats
    us?</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549168null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/549161?ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/549161?ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549161null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Report-From-India/ArticleStandard/Article/detail/549536?ref=25">

    <title>Report From: India</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Report-From-India/ArticleStandard/Article/detail/549536?ref=25</link>

    <description>Differential pricing is making more than just an appearance in Asia's pharma market these
    days.</description>

    <dc:date>2008-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/549536null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Industrial-Applications-of-Whole-Cell-Biocatalysis/ArticleStandard/Article/detail/548828?ref=25">

    <title>Industrial Applications of Whole-Cell Biocatalysis</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Industrial-Applications-of-Whole-Cell-Biocatalysis/ArticleStandard/Article/detail/548828?ref=25</link>

    <description>Recombinant microbial whole-cell biocatalysis is a valuable approach for producing enantiomerically
    pure intermediates. The authors examine several groups of enzymes using this approach: dehydrogenases,
    hydantoinases, and acylases.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548828null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Highly-Efficient-Olefin-Metathesis-Catalysts/ArticleStandard/Article/detail/548825?ref=25">

    <title>Highly Efficient Olefin-Metathesis Catalysts</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Highly-Efficient-Olefin-Metathesis-Catalysts/ArticleStandard/Article/detail/548825?ref=25</link>

    <description>The authors describe the Piers' catalysts and detail latest progress in olefin-metathesis catalyst
    technology.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548825null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Manufacturing-Considerations-for-Sourcing-GMP-Ferm/ArticleStandard/Article/detail/548826?ref=25">

    <title>Manufacturing Considerations for Sourcing GMP Fermentation Services</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Manufacturing-Considerations-for-Sourcing-GMP-Ferm/ArticleStandard/Article/detail/548826?ref=25</link>

    <description>The authors describe the critical aspects of an ideal fermentation services provider.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548826null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Power-Ultrasound-and-the-Production-of-Mesoscopic-/ArticleStandard/Article/detail/548822?ref=25">

    <title>Power Ultrasound and the Production of Mesoscopic Particles and Aqueous Dispersions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Power-Ultrasound-and-the-Production-of-Mesoscopic-/ArticleStandard/Article/detail/548822?ref=25</link>

    <description>The authors discuss advanced sonocrystallization particle-engineering techniques for manufacturing
    mesoscopic particles.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548822null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/High-Potency-APIs-Containment-and-Handling-Issues/ArticleStandard/Article/detail/548824?ref=25">

    <title>High-Potency APIs: Containment and Handling Issues</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/High-Potency-APIs-Containment-and-Handling-Issues/ArticleStandard/Article/detail/548824?ref=25</link>

    <description>The author explains the planning, equipment, and facility design requried for manufacturing HPAPIs and
    specialized requirements for handling these compounds.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548824null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Epedigree-in-the-Pharmaceutical-Supply-Chain/ArticleStandard/Article/detail/548823?ref=25">

    <title>Epedigree in the Pharmaceutical Supply Chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Epedigree-in-the-Pharmaceutical-Supply-Chain/ArticleStandard/Article/detail/548823?ref=25</link>

    <description>EPedigree, track-and-trace technologies, and other tools for optimizing supply-chain management are of
    increasing importance to the pharmaceutical industry. The author examines the current regulatory and legislative
    framework for ePedigree for finished drug products as well as proposals to require electronic statements for
    pharmaceutical ingredients.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548823null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Expansion-Activity-of-CMOs/ArticleStandard/Article/detail/548827?ref=25">

    <title>Expansion Activity of CMOs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Expansion-Activity-of-CMOs/ArticleStandard/Article/detail/548827?ref=25</link>

    <description>The outlook is fairly optimistic as contract manufacturing organizations (CMOs) gather at CPhI
    Worldwide in Frankfurt. CMOs are expanding capacity for small-molecules, biologics, and finished-product
    manufacturing.</description>

    <dc:date>2008-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372008/548827null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Economic-Impact-Increases-but-Employment-Falls-for/ArticleStandard/Article/detail/545161?ref=25">

    <title>Economic Impact Increases but Employment Falls for NJ Life-Science Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Economic-Impact-Increases-but-Employment-Falls-for/ArticleStandard/Article/detail/545161?ref=25</link>

    <description>The Healthcare Institute of New Jersey (HINJ) released a new research study showing that New Jersey's
    life-science industry experienced stable growth in 2007.</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545161null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/King-Pharmaceuticals-Bids-14-Billion-for-Alpharma/ArticleStandard/Article/detail/545160?ref=25">

    <title>King Pharmaceuticals Bids $1.4 Billion for Alpharma</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/King-Pharmaceuticals-Bids-14-Billion-for-Alpharma/ArticleStandard/Article/detail/545160?ref=25</link>

    <description>The specialty drug company King Pharmaceuticals is seeking to acquire the specialty pharmaceutical
    company Alpharma (Bridgewater, NJ) through an unsolicited bid of $33 per share or $1.4 billion in cash. Alpharma
    has rejected the bid.</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545160null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Time-is-Running-out-for-Innovation-Awards/ArticleStandard/Article/detail/545141?ref=25">

    <title>Time is Running out for Innovation Awards</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Time-is-Running-out-for-Innovation-Awards/ArticleStandard/Article/detail/545141?ref=25</link>

    <description>The deadline for nominations for the Innovations in Pharma Science Awards is here. Check out
    http://pharmtech.com/Innovations to nominate your company's work in one of five areas by next week</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545141null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Public-Comment-on-Cough-and-Cold-Meds-for-Kids/ArticleStandard/Article/detail/545159?ref=25">

    <title>Public Comment on Cough and Cold Meds for Kids</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Public-Comment-on-Cough-and-Cold-Meds-for-Kids/ArticleStandard/Article/detail/545159?ref=25</link>

    <description>The US Food and Drug Administration will hold a public hearing Oct. 2, 2008, to obtain input regarding
    over-the-counter (OTC) cough and cold drugs marketed for pediatric use.</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545159null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Finalizes-Labeling-Changes-Rule/ArticleStandard/Article/detail/545146?ref=25">

    <title>FDA Finalizes Labeling Changes Rule</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Finalizes-Labeling-Changes-Rule/ArticleStandard/Article/detail/545146?ref=25</link>

    <description>FDA has finalized a regulation regarding changes to an approved new drug application (NDA), biologics
    license application (BLA), or medical device premarket approval applicatin (PMA).</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545146null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-Gilead-Sciences-to-Expand/ArticleStandard/Article/detail/545230?ref=25">

    <title>Company and People Notes: Gilead Sciences to Expand Headquarters and add 1900 Jobs, WuXi Appoints Rujian Ma
    as VP of Synthetic Chemistry, More</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-Gilead-Sciences-to-Expand/ArticleStandard/Article/detail/545230?ref=25</link>

    <description>Also, Shire recalls &amp;#34;Daytrana&amp;#34; patch, Chromatide forms Scientific Advisory Board,
    more...</description>

    <dc:date>2008-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352008/545230null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-to-Acquire-Talecris-B/ArticleStandard/Article/detail/543542?ref=25">

    <title>Company and People Notes: CSL to Acquire Talecris, Benda Appoints George Zhou COO, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-to-Acquire-Talecris-B/ArticleStandard/Article/detail/543542?ref=25</link>

    <description>Also, Tekmira will collaborate with Bristol-Myers Squibb, Helicos Biosciences appoints Steve Lombardi
    CEO, more...</description>

    <dc:date>2008-08-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/543542null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Misuse-of-Narcotics-May-Call-for-Additional-Doctor/ArticleStandard/Article/detail/543483?ref=25">

    <title>Misuse of Narcotics May Call for Additional Doctor Training</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Misuse-of-Narcotics-May-Call-for-Additional-Doctor/ArticleStandard/Article/detail/543483?ref=25</link>

    <description>The US Food and Drug Administration may soon ask doctors to undergo special training to be able to
    prescribe powerful narcotics, Dr. Bob Rappaport told The New York Times last week. Rappaport, director of FDA's
    Anesthesia, Analgesia and Rheumatology Products division, said the agency is considering recommending additional
    education for doctors in early 2009.</description>

    <dc:date>2008-08-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/543483null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Expresses-Trade-Concerns-with-REACH-Implemen/ArticleStandard/Article/detail/543486?ref=25">

    <title>SOCMA Expresses Trade Concerns with REACH Implementation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Expresses-Trade-Concerns-with-REACH-Implemen/ArticleStandard/Article/detail/543486?ref=25</link>

    <description>The Synthetic Organic Chemical Manufacturers Association (SOCMA) is expressing trade concerns with the
    European Union's REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation, a new
    European Union policy on chemicals and their safe use.</description>

    <dc:date>2008-08-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/543486null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Testing/USP-Opens-Site-in-Brazil/ArticleStandard/Article/detail/543484?ref=25">

    <title>USP Opens Site in Brazil</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Testing/USP-Opens-Site-in-Brazil/ArticleStandard/Article/detail/543484?ref=25</link>

    <description>The US Pharmacopeial Conventional added to its international sites with the official opening of its
    facility in Sao Paulo, Brazil.</description>

    <dc:date>2008-08-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/543484null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/August-2008-Editors-Picks-Products-from-OYSTAR-Man/ArticleStandard/Article/detail/542946?ref=25">

    <title>August 2008 Editor's Picks: Products from OYSTAR Manesty and Hawk</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/August-2008-Editors-Picks-Products-from-OYSTAR-Man/ArticleStandard/Article/detail/542946?ref=25</link>

    <description>PharmTech's monthly newsletter, Equipment &amp;amp;amp; Processing Report, reviews the Editor's Picks
    for the August 2008 edition from OYSTAR Manesty and Hawk.</description>

    <dc:date>2008-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/542946null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/After-Formaldehyde-Comparing-Alternative-Decontami/ArticleStandard/Article/detail/542595?ref=25">

    <title>After Formaldehyde: Comparing Alternative Decontaminants</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/After-Formaldehyde-Comparing-Alternative-Decontami/ArticleStandard/Article/detail/542595?ref=25</link>

    <description>Decontaminating pharmaceutical manufacturing facilities is essential for producing safe and pure
    drugs. The most commonly used decontaminant in the industry has been sublimated formaldehyde.</description>

    <dc:date>2008-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542595null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/How-to-Be-Green-in-a-CGMP-Regulated-Environment/ArticleStandard/Article/detail/542939?ref=25">

    <title>How to Be Green in a CGMP-Regulated Environment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/How-to-Be-Green-in-a-CGMP-Regulated-Environment/ArticleStandard/Article/detail/542939?ref=25</link>

    <description>The concept of the the triple bottom line incorporates a company's financial, social, and
    environmental performance. As a result, an increasing number of companies are investigating how sustainable, green
    technologies and practices can help them stay competitive in a challenging regulated market.</description>

    <dc:date>2008-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342008/542939null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Seeks-Contractors-for-Sentinel-System/ArticleStandard/Article/detail/542060?ref=25">

    <title>FDA Seeks Contractors for Sentinel System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Seeks-Contractors-for-Sentinel-System/ArticleStandard/Article/detail/542060?ref=25</link>

    <description>The US Food and Drug Administration seeks contractors that will identify, describe, and evaluate
    potential data sources or data environments that could participate in the agency's Sentinel
    Initiative.</description>

    <dc:date>2008-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542060null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Actavis-Voluntary-Recalls-Products-for-GMP-Violati/ArticleStandard/Article/detail/542065?ref=25">

    <title>Actavis Voluntary Recalls Products for GMP Violations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Actavis-Voluntary-Recalls-Products-for-GMP-Violati/ArticleStandard/Article/detail/542065?ref=25</link>

    <description>Actavis Totowa LLC, the US subsidiary of the generic drug manufacturer Actavis Group, is announcing a
    voluntary recall to the retail level of all drug products manufactured at its Little Falls, New Jersey, facility.
    This is a precautionary, voluntary action by Actavis following an inspection conducted by the Food and Drug
    Administration earlier this year.</description>

    <dc:date>2008-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542065null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Rejects-Roches-/ArticleStandard/Article/detail/542276?ref=25">

    <title>Company and People Notes: Genentech Rejects Roche's Bid, TorreyPines CEO Retires, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Rejects-Roches-/ArticleStandard/Article/detail/542276?ref=25</link>

    <description>Also, Ortho Biotech recalls one lot of &amp;#34;Procrit&amp;#34; due to cracked vials, more
    appointments at Actavis, more...</description>

    <dc:date>2008-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542276null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/FDA-Releases-Draft-Guidance-on-Residual-Solvents/ArticleStandard/Article/detail/542062?ref=25">

    <title>FDA Releases Draft Guidance on Residual Solvents</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/FDA-Releases-Draft-Guidance-on-Residual-Solvents/ArticleStandard/Article/detail/542062?ref=25</link>

    <description>The US Food and Drug Administration has distributed a draft of Guidance for Industry: Residual
    Solvents in Drug Products Marketed in the United States for public comment.</description>

    <dc:date>2008-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542062null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sterile-Manufacturing-Draft-Guidance-Provides-Appl/ArticleStandard/Article/detail/542067?ref=25">

    <title>Sterile Manufacturing Draft Guidance Provides Application Information</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sterile-Manufacturing-Draft-Guidance-Provides-Appl/ArticleStandard/Article/detail/542067?ref=25</link>

    <description>The US Food and Drug Administration issued a new draft guidance for public comment on sterile
    manufacturing.</description>

    <dc:date>2008-08-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/542067null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Magnetic-Mixers-How-Are-They-Different/ArticleStandard/Article/detail/535012?ref=25">

    <title>Magnetic Mixers: How Are They Different?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Magnetic-Mixers-How-Are-They-Different/ArticleStandard/Article/detail/535012?ref=25</link>

    <description>Magnetic mixers are known to offer significant processing advantages over other types of mixers. This
    white paper touches on those differences, but focuses heavily on the differences between the different magnetic
    mixer designs. It highlights some of the most common issues with magnetic mixing, and how one mixer has overcome
    these issues.</description>

    <dc:date>2008-08-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332008/535012null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/BMS-Bids-45-Billion-for-ImClone-Systems/ArticleStandard/Article/detail/534324?ref=25">

    <title>BMS Bids $4.5 Billion for ImClone Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/BMS-Bids-45-Billion-for-ImClone-Systems/ArticleStandard/Article/detail/534324?ref=25</link>

    <description>Bristol-Myers Squibb is seeking to acquire the biopharmaceutical company ImClone Systems (New York)
    for $4.5 billion or $60 per share. BMS currently holds a 17% stake in ImClone.</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534324null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Meda-will-Acquire-Valeant/ArticleStandard/Article/detail/534390?ref=25">

    <title>Company and People Notes: Meda will Acquire Valeant's Western and Eastern European Businesses, Catalent
    Names George L. Fotiades Interim President and CEO, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Meda-will-Acquire-Valeant/ArticleStandard/Article/detail/534390?ref=25</link>

    <description>Also, Bilcare Global Clinical Supplies opens new headquarters in San Francisco, Sigurdur Oli Olafsson
    named CEO of Actavis Group, more...</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534390null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Revised-Discussion-Draft-of-FDA-Globalization-Act-/ArticleStandard/Article/detail/534325?ref=25">

    <title>Revised Discussion Draft of FDA Globalization Act Further Tightens the Supply Chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Revised-Discussion-Draft-of-FDA-Globalization-Act-/ArticleStandard/Article/detail/534325?ref=25</link>

    <description>The House Committee on Energy and Commerce issued a revised discussion draft to the Food and Drug
    Administration Globalization Act of 2008.</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534325null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Fire-rated-pallets-What-you-need-to-know/ArticleStandard/Article/detail/534538?ref=25">

    <title>Fire-rated pallets: What you need to know</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Fire-rated-pallets-What-you-need-to-know/ArticleStandard/Article/detail/534538?ref=25</link>

    <description>This paper attempts to identify some of the specifics of the process used to obtain approval for use
    of plastic pallets as equivalent to wood pallets for use in warehouse storage. This paper is written to look at the
    issue in general and is not intended to cover all storage situations. Your specific situation should be evaluated
    by a fire protection specialist.</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534538null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDAs-Complete-Responses-Commence/ArticleStandard/Article/detail/534316?ref=25">

    <title>FDA's Complete Responses Commence</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDAs-Complete-Responses-Commence/ArticleStandard/Article/detail/534316?ref=25</link>

    <description>Next week, the US Food and Drug Administration's communications with pharmaceutical companies will
    change, and the agency will begin issuing complete response letters in place of approvable letters.</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534316null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/User-Fee-Rates-for-FY-2009-Announced/ArticleStandard/Article/detail/534323?ref=25">

    <title>User Fee Rates for FY 2009 Announced</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/User-Fee-Rates-for-FY-2009-Announced/ArticleStandard/Article/detail/534323?ref=25</link>

    <description>The US Food and Drug Administration released its user fee rates for fiscal year 2009 last
    Friday.</description>

    <dc:date>2008-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534323null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Fundamentals-Are-Strong-for-Global-CRO-Market/ArticleStandard/Article/detail/533225?ref=25">

    <title>Fundamentals Are Strong for Global CRO Market</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Fundamentals-Are-Strong-for-Global-CRO-Market/ArticleStandard/Article/detail/533225?ref=25</link>

    <description>Strong profitability and good growth prospects bode well for the global market for contract research
    organizations.</description>

    <dc:date>2008-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312008/533225null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing-Practices-Scrutinized-by-Congress/ArticleStandard/Article/detail/533228?ref=25">

    <title>Outsourcing Practices Scrutinized by Congress</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing-Practices-Scrutinized-by-Congress/ArticleStandard/Article/detail/533228?ref=25</link>

    <description>The pharmaceutical industry?s outsourcing practices receive increased attention as Congress evaluates
    the role of outsourcing in drug-safety issues.</description>

    <dc:date>2008-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312008/533228null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/533290?ref=25">

    <title>Help Your Contract Laboratory Help You</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Help-Your-Contract-Laboratory-Help-You/ArticleStandard/Article/detail/533290?ref=25</link>

    <description>Providing the right information upfront may ease new requirements to assess solvent
    levels.</description>

    <dc:date>2008-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312008/533290null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Saved-by-the-Delay/ArticleStandard/Article/detail/534710?ref=25">

    <title>Saved by the Delay</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Saved-by-the-Delay/ArticleStandard/Article/detail/534710?ref=25</link>

    <description>Postponement of California's deadline gives the supply chain time to refine ePedigree
    solutions.</description>

    <dc:date>2008-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534710null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/FDA-and-Medicare-at-Odds/ArticleStandard/Article/detail/534698?ref=25">

    <title>FDA and Medicare at Odds?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/FDA-and-Medicare-at-Odds/ArticleStandard/Article/detail/534698?ref=25</link>

    <description>Legislative decisions to increase Medicare's formulary may lead to a fight over drug
    approvals.</description>

    <dc:date>2008-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534698null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Suspicious-Times/ArticleStandard/Article/detail/534700?ref=25">

    <title>Suspicious Times</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Suspicious-Times/ArticleStandard/Article/detail/534700?ref=25</link>

    <description>Agents report unusual chemistry, abnormal data analysis, and unconventional work
    practices.</description>

    <dc:date>2008-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534700null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Charting-Advances-at-CRS/ArticleStandard/Article/detail/534699?ref=25">

    <title>Charting Advances at CRS</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Charting-Advances-at-CRS/ArticleStandard/Article/detail/534699?ref=25</link>

    <description>This year's meeting of the Controlled Release Society unveiled a plethora of research
    insights.</description>

    <dc:date>2008-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322008/534699null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


